首页 | 本学科首页   官方微博 | 高级检索  
     


Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia
Authors:Langabeer Stephen E  McCarron Sarah L  Carroll Peig  Kelly Johanna  O'Dwyer Michael  Conneally Eibhlin
Affiliation:Cancer Molecular Diagnostics, Central Pathology Laboratory, St. James's Hospital, Dublin 8, Ireland; Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland; Cancer Clinical Trials, St. James's Hospital, Dublin, Ireland; National Centre for Medical Genetics, Our Lady's Children's Hospital, Dublin, Ireland; Department of Haematology, National University of Ireland, Galway, Ireland; Department of Haematology, St. James's Hospital, Dublin, Ireland
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号